The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of mild to moderate Alzheimer’s disease (review of TA111): a systematic review and economic model

M Bond , G Rogers, J Peters, R Anderson, M Hoyle, A Miners, T Moxham, S Davis, P Thokala, Allan Wailoo, M Jeffreys, C Hyde

Research output: Contribution to journalArticlepeer-review

167 Citations (Scopus)
17 Downloads (Pure)

Fingerprint Dive into the research topics of 'The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of mild to moderate Alzheimer’s disease (review of TA111): a systematic review and economic model'. Together they form a unique fingerprint.

Medicine & Life Sciences